Effect of Mustadi Yapana Basti Punarnavadi Ghanavati Veerataradi Ghanavati Trikantakadi Ghanavati in Chronic Kidney Disease

Phase 2

• Conditions: Health Condition 1: N182- Chronic kidney disease, stage 2 (mild)Health Condition 2: N189- Chronic kidney disease, unspecified

• Registration Number: CTRI/2023/02/050137
• Lead Sponsor: Dr Ashwini Sajjanavar

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 March 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Diagnosed cases of Chronic Kidney Disease Patients.

• Subjects who are fit for Bastikarma.

• Subjects having classical common signs and symptoms Gaurava,Anavasthita

utseda,Siratanutwa,Salomaharsha,Angavivarnata,Sashoolamutrata,Raktamootrata.

• Subjects with classical symptoms of Chronic Kidney Disease having clinical features like oedema,pruritis,

generalized weakness, nausea.

• Stages 1, 2 and 3 Glomerular Filtration Rate (30-ml/min per 1.73m2

)

• Microalbuminuria( ACR- 30 to 300mg/g >=3 months)

• Mild hypertension( <130/80MMHG)

• Patients aged between 20-70years.

• Patients of either sex will be taken for study.

Exclusion Criteria

Patients of Congenital Renal Diseases like Autosomal dominant and Recessive Polycystic Kidney disease,

Congenital Nephrotic syndrome (Finnish type), Alportâ??s syndrome, Fabryâ??s disease and

Juvenile Nephronopthisis.

• Subjects who are on dialysis.

• Uncontrolled Dm.(HBA1C >=7)

• Pregnant women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified